A real-world PMS study based on a large population demonstrates comparable safety profile of SB11 (B

NASHVILLE, Tenn., July 20, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of oph

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Harrow (NASDAQ:HROW), a leading provider of ophthalmic disease management solutions in North America

Expands Harrow's Growing Retina Portfolio with an Interchangeable Ranibizumab Biosimilar Expands Har

INCHEON, Korea--(BUSINESS WIRE)-- #Byooviz--Samsung Bioepis Co., Ltd. today announced the relaunch o

Harrow shares gain after relaunching Verkazia in the United States, aiming to improve access to an F

Harrow Inc. (NASDAQ:HROW) on Wednesday announced the relaunch of VERKAZIA (cyclosporine ophthalmic e

NASHVILLE, Tenn., June 10, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of oph

NASHVILLE, Tenn., May 27, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of opht

MONSEY, N.Y., May 13, 2026 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating

Harrow, Inc. (HROW) Q1 2026 Earnings Call Transcript

Harrow NASDAQ: HROW executives said the company's first-quarter results were weighed down by a discr

U.S. stock futures lower, Nasdaq down 200 points. AST SpaceMobile shares dip 11% after reporting wor

Harmonic Inc (HLIT) rose in pre-market trading after beating earnings expectations & raising gui

Harrow (HROW) came out with a quarterly loss of $0.63 per share versus the Zacks Consensus Estimate

First Quarter 2026 and Selected Highlights:  VEVYE® delivered record new and total prescription perf

Harrow (HROW) doesn't possess the right combination of the two key ingredients for a likely earnings

NASHVILLE, Tenn., April 27, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of op

State of Alaska Department of Revenue lifted its holdings in shares of Harrow, Inc. (NASDAQ: HROW) b

Harrow has delivered a decade-long 40% CAGR in revenue, with robust operating leverage and EBITDA ma

NASHVILLE, Tenn., April 16, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of op

OLIVE BRANCH, Miss., April 14, 2026 /PRNewswire/ -- LogiCare3PL today announced it has been selected

Harrow is rated a 'Strong Buy' with a fair value of $73.25, implying 104% upside from current levels

MDB stock fell 27.2% in pre-market trading after reporting Q4 earnings of $1.65 per share, revenue o

Shares of Ouster Inc (NASDAQ:OUST) rose sharply in pre-market trading after the company reported bet

U.S. stock futures lower, Dow futures down 1%. Yatsen Holding shares fall 10.1%, while other stocks

Jim Cramer takes a look at Harrow, Pfizer, Kinsale Capital, Manulife Financial, Iron Mountain and mo

  On Wednesday, 807 companies reached new 52-week lows.

Gainers Synthetic Biologics, Inc. (NYSE: SYN) shares climbed 100% to close at $1.00 on Tuesday af

Stocks That Hit 52-Week Lows On Thursday

Stocks That Hit 52-Week Lows On Monday

Stocks That Hit 52-Week Lows On Thursday